Vitamin E Supplement Protects Against Gestational Diabetes Mellitus in Mice Through nuclear factor-erythroid factor 2-related factor 2/heme oxygenase-1 Signaling Pathway
- PMID: 36883138
- PMCID: PMC9985888
- DOI: 10.2147/DMSO.S397255
Vitamin E Supplement Protects Against Gestational Diabetes Mellitus in Mice Through nuclear factor-erythroid factor 2-related factor 2/heme oxygenase-1 Signaling Pathway
Abstract
Background: Gestational diabetes mellitus (GDM) is the most common pregnant disorder worldwide. In this study, we aimed to explore whether vitamin E (VE) treatment alone could protect against GDM in a mouse model.
Methods: 6-week-old C57BL/6J female mice were fed on high-fat diet for two weeks and continued with high-fat diet after pregnancy to induce GDM. The pregnant mice were orally administrated with 2.5, 25 or 250 mg/kg VE twice per day during pregnancy together with high-fat diet. Oral glucose tolerance test, insulin amounts, oxidative stress and inflammation were then measured.
Results: Only 250 mg/kg VE could improve glucose tolerance and insulin level in pregnant mice. VE (250 mg/kg) effectively inhibited GDM-induced hyperlipidemia, and secretion of inflammatory cytokines such as tumor necrosis factor-α and interleukin-6. VE also significantly ameliorated maternal oxidative stress at the late stage of pregnancy, and also improved reproductive outcomes, including increasing the litter size and birth weight in GDM mice. Moreover, VE also activated GDM-reduced nuclear factor-erythroid factor 2-related factor 2 (Nrf2) / heme oxygenase-1 signaling pathway in the maternal liver tissues of GDM mice.
Conclusion: Our data clearly demonstrated that 250 mg/kg VE twice a day during pregnancy could significantly ameliorate the symptoms of GDM by alleviating oxidative stress, inflammation, hyperglycemia, and hyperlipidemia through Nrf2/HO-1 signaling pathway in GDM mice. Thus, additional VE supplement might be beneficial to GDM.
Keywords: Nrf2; fetus; gestational diabetes mellitus; oxidative stress; vitamin E.
© 2023 Lin and Zhang.
Conflict of interest statement
The authors declared that they have no conflict of interest.
Figures
Similar articles
-
N-acetyl-L-cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress.Biotechnol Appl Biochem. 2023 Jun;70(3):1128-1136. doi: 10.1002/bab.2426. Epub 2022 Dec 27. Biotechnol Appl Biochem. 2023. PMID: 36517965
-
Hypoxia-reoxygenation treatment attenuates gestational diabetes mellitus.Endocr Connect. 2021 Jan;10(1):84-91. doi: 10.1530/EC-20-0555. Endocr Connect. 2021. PMID: 33320105 Free PMC article.
-
Tertiary butylhydroquinone alleviates gestational diabetes mellitus in C57BL/KsJ-Lep db/+ mice by suppression of oxidative stress.J Cell Biochem. 2019 Sep;120(9):15310-15319. doi: 10.1002/jcb.28798. Epub 2019 May 3. J Cell Biochem. 2019. PMID: 31050362
-
[Gestational diabetes mellitus (Update 2019)].Wien Klin Wochenschr. 2019 May;131(Suppl 1):91-102. doi: 10.1007/s00508-018-1419-8. Wien Klin Wochenschr. 2019. PMID: 30980150 Review. German.
-
Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis?Front Endocrinol (Lausanne). 2022 Jun 23;13:916042. doi: 10.3389/fendo.2022.916042. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35813659 Free PMC article. Review.
References
-
- Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(Suppl 2):B161–B167. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources